NEI VFQ-25 subscale scores and ocular composite score (OCS), Mean ± S.

<p>NEI VFQ-25 subscale scores and ocular composite score (OCS), Mean ± S.</p

NEI VFQ-25 subscale scores and overall composite score (OCS), Mean ± SD.

<p>NEI VFQ-25: National Eye Institute Visual Functioning Questionnaire-25, GH: General Health, GV: General Vision, OP: Ocular Pain, NA: Near Activities, DA: Distance Activities, VSSF: Vision Specific Social Functioning, VSMH: Vision Specific Mental Health, VSRD: Vision Specific Role Difficulties, VSD: Vision Specific Dependency, D: Driving, CV: Color Vision, PV: Peripheral Vision, OCS: Overall Composite Score, HSV: Herpes Simplex Virus, VZV: Varicella Zoster Virus. Mean scores ± one standard deviation are given.</p><p>^a Average of vision-targeted subscale scores, without GH. ^b Bonferroni correction, significance level p<0.017. ^c Missing data in three patients.</p

NEI VFQ-25 subscale scores and overall composite score (OCS), Mean ± SD.

<p>NEI VFQ-25: National Eye Institute Visual Functioning Questionnaire-25, GH: General Health, GV: General Vision, OP: Ocular Pain, NA: Near Activities, DA: Distance Activities, VSSF: Vision Specific Social Functioning, VSMH: Vision Specific Mental Health, VSRD: Vision Specific Role Difficulties, VSD: Vision Specific Dependency, D: Driving, CV: Color Vision, PV: Peripheral Vision, OCS: Overall Composite Score, IOP: Intraocular Pressure. Mean scores ± one standard deviation are given.</p><p>^a Average of vision-targeted subscale scores, without GH. ^b No keratitis in history or keratitis in history without residuals. ^c Keratitis with residuals. ^d Medical chronic condition or medical condition with large impact, recent or in the past, except for uveitis. ^e At least one eye with Snellen visual acuity <0.5. Measured with Snellen chart within six months before or after completing the NEI VFQ-25. ^f Missing data in four patients. ^g Treatment of the uveitis and/or complications at the moment of completing the NEI VFQ-25.</p

NEI VFQ-25 subscale scores and OCS compared with literature.

<p>NEI VFQ-25: National Eye Institute Visual Function Questionnaire-25. GH: General Health, GV: General Vision, OP: Ocular Pain, NA: Near Activities, DA: Distance Activities, VSSF: Vision Specific Social Functioning, VSMH: Vision Specific Mental Health, VSRD: Vision Specific Role Difficulties, VSD: Vision Specific Dependency, D: Driving, CV: Color Vision, PV: Peripheral Vision, OCS: Overall Composite Score.</p><p>^a Average of vision-targeted subscale scores, without GH. ^b 12 months after receiving infliximab. ^c Six week follow-up visit.</p

Spearman’s Rank Correlations between studied variables and NEI VFQ-25 subscale scores and OCS.

<p>NEI VFQ-25: National Eye Institute Visual Function Questionnaire-25, GH: General Health, GV: General Vision, OP: Ocular Pain, NA: Near Activities, DA: Distance Activities, VSSF: Vision Specific Social Functioning, VSMH: Vision Specific Mental Health, VSRD: Vision Specific Role Difficulties, VSD: Vision Specific Dependency, D: Driving, CV: Color Vision, PV: Peripheral Vision, OCS: Overall Composite Score, VA: Visual Acuity, BDI: Beck Depression Inventory, SSL-I: Social Support List - Interactions, SSL-D: Social Support List – Discrepancies.</p><p>^a Average of vision-targeted subscale scores, without GH.</p

NEI VFQ-25 subscale scores and OCS compared with literature.

<p>NEI VFQ-25 subscale scores and OCS compared with literature.</p

clinical characteristics of HLA-B27 associated AU patients and overall scores on questionnaires (N and (%) or Mean ± SD (range)).

<p>clinical characteristics of HLA-B27 associated AU patients and overall scores on questionnaires (N and (%) or Mean ± SD (range)).</p

Spearman’s Rank Correlations between studied variables and NEI VFQ-25 subscale scores and OCS.

<p>Spearman’s Rank Correlations between studied variables and NEI VFQ-25 subscale scores and OCS.</p

NEI VFQ-25 overall composite score and subscale scores (mean ± SD).

<p>Nominal significant values are indicated in bold.</p><p>NEI VFQ-25: National Eye Institute Visual Functioning Questionnaire-25, SD: standard deviation, GH: General Health, GV: General vision, OP: Ocular pain, NA: Near activities, DA: Distance activities, VSSF: Vision Specific Social Functioning, VSMH: Vision Specific Mental Health, VSRD: Vision Specific Role Difficulties, VSD: Vision Specific Dependency, D: Driving, CV: Color Vision, PV: Peripheral Vision, OCS: Overall Composite Score, PVR: Proliferative vitreoretinopathy, PPV: Pars Plana Vitrectomy.</p>a<p>Average of vision-targeted subscale scores, without GH.</p>b<p>Family history of RRD.</p>c<p>Numbers of detached retinal quadrants at presentation.</p>d<p>Duration of macular detachment.</p>e<p>Number of re-detachments.</p>f<p>PPV with or without an encircling band.</p>g<p>Postoperative tamponade after PPV; SF6 gas (short acting) versus C3F8 gas & silicon oil (long acting).</p><p>NEI VFQ-25 overall composite score and subscale scores (mean ± SD).</p

Visual function tests in operated versus in fellow control eyes.

<p>BCVA: best corrected visual acuity, CCI: Color Confusion Indices, SD: standard deviation, HM: hand movements. Postoperative measurements were performed 12 months after retinal detachment surgery.</p>a<p>Mean LogMAR visual acuity converted to Snellen visual acuity.</p><p>Visual function tests in operated versus in fellow control eyes.</p